US national surveillance shows Candida auris clinical cases more than doubled from 2022 to 2024, according to CDC reporting cited in a recent summary. The rise is concentrated among older adults and remains tightly linked to healthcare settings where the fungus can spread via contaminated surfaces and colonized patients. The updates also note that expanded screening and changes in testing practices may contribute to part of the increase, but the overall direction reinforces the urgency of containment and diagnostic rigor in hospitals and long-term care facilities.